Cargando…
Neuropilin-1 as Therapeutic Target for Malignant Melanoma
Neuropilin-1 (NRP-1) is a transmembrane glycoprotein that acts as a co-receptor for various members of the vascular endothelial growth factor (VEGF) family. Its ability to bind or modulate the activity of a number of other extracellular ligands, such as class 3 semaphorins, TGF-β, HGF, FGF, and PDGF...
Autores principales: | Graziani, Grazia, Lacal, Pedro M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453476/ https://www.ncbi.nlm.nih.gov/pubmed/26090340 http://dx.doi.org/10.3389/fonc.2015.00125 |
Ejemplares similares
-
Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma
por: Ruffini, Federica, et al.
Publicado: (2015) -
Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1
por: Ruffini, Federica, et al.
Publicado: (2017) -
Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma
por: Ceci, Claudia, et al.
Publicado: (2020) -
Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors
por: Douyère, Manon, et al.
Publicado: (2021) -
Neuropilin‐1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1
por: Colotti, Gianni, et al.
Publicado: (2021)